Ngā hua rapu kaituhi

1

Utility of IL-28B Polymorphisms in the Era of Direct-Acting Antiviral Therapy mā Gordon, Stuart C.

I whakaputaina 2011

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
2

Polycystic Liver Disease mā Gordon, Stuart C.

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
3

Hepatitis C Virus Detection and Treatment in Rural Communities mā Gordon, Stuart C.

I whakaputaina 2018

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
4

Update on Polycystic Liver Disease mā Gordon, Stuart C.

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
5

Epidemiology of Hepatitis C mā Jafri, Syed‐Mohammed, Gordon, Stuart C.

I whakaputaina 2018

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
6

Is there still a role for liver biopsy in managing hepatitis C virus infections? mā Jafri, Syed‐Mohammed R., Gordon, Stuart C.

I whakaputaina 2012

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
7

Management of Direct‐Acting Antiviral Failures mā Alimirah, Maryam, Sadiq, Omar, Gordon, Stuart C.

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
8

Response to: ‘No impact of Covid‐19 pandemic on decompensation of alcoholic liver disease: Results from a single Center in Milan’ mā Gonzalez, Humberto C., Rupp, Loralee B., Trudeau, Sheri, Gordon, Stuart C.

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
9

A randomized controlled trial of thymalfasin plus transarterial chemoembolization for unresectable hepatocellular carcinoma mā Gish, Robert G., Gordon, Stuart C., Nelson, David, Rustgi, Vinod, Rios, Israel

I whakaputaina 2009

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
10

Assessment of cost of innovation versus the value of health gains associated with treatment of chronic hepatitis C in the United States: The quality-adjusted cost of care mā Younossi, Zobair M., Park, Haesuk, Dieterich, Douglas, Saab, Sammy, Ahmed, Aijaz, Gordon, Stuart C.

I whakaputaina 2016

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
11

Health Care Use and Costs Among Patients With Nonalcoholic Steatohepatitis With Advanced Fibrosis Using the Fibrosis‐4 Score mā Gordon, Stuart C., Kachru, Nandita, Parker, Emily, Korrer, Stephanie, Ozbay, A. Burak, Wong, Robert J.

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
12

Validity of an automated algorithm using diagnosis and procedure codes to identify decompensated cirrhosis using electronic health records mā Lu, Mei, Chacra, Wadih, Rabin, David, Rupp, Loralee B, Trudeau, Sheri, Li, Jia, Gordon, Stuart C

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
13

A Case of Hemophagocytic Lymphohistiocytosis Secondary to Disseminated Histoplasmosis mā Columbus-Morales, Ivan, Maahs, Lucas, Husain, Sanam, Gordon, Stuart C., Inamdar, Kedar V., Gonzalez, Humberto C.

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
14

Real-world Comorbidity Burden, Health Care Utilization, and Costs of Nonalcoholic Steatohepatitis Patients With Advanced Liver Diseases mā Wong, Robert J., Kachru, Nandita, Martinez, Diane J., Moynihan, Meghan, Ozbay, A. Burak, Gordon, Stuart C.

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
15

Hepatitis B e Antigen Status and Hepatitis B DNA Levels in Women of Childbearing Age with Chronic Hepatitis B Infection Screening for Clinical Trials mā Tran, Tram T., Gordon, Stuart C., Fung, Scott, Dinh, Phillip, Yee, Leland, Martins, Eduardo Bruno, Buti, Maria, Marcellin, Patrick

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
16

Baricitinib and primary biliary cholangitis mā Gordon, Stuart C., Trudeau, Sheri, Regev, Arie, Uhas, Jonathan M., Chakladar, Sujatro, Pinto-Correia, Ana, Gottlieb, Klaus, Schlichting, Doug

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
17

Differences in Hepatic Phenotype Between Hemochromatosis Patients with HFE C282Y Homozygosity and Other HFE Genotypes mā Cheng, Raymond, Barton, James C., Morrison, Elizabeth D., Phatak, Pradyumna D., Krawitt, Edward L., Gordon, Stuart C., Kowdley, Kris V.

I whakaputaina 2009

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
18

Advancing Age and Comorbidity in a US Insured Population‐Based Cohort of Patients With Chronic Hepatitis B mā Nguyen, Mindie H., Lim, Joseph K., Burak Ozbay, A., Fraysse, Jeremy, Liou, Iris, Meyer, Nicole, Dusheiko, Geoffrey, Gordon, Stuart C.

I whakaputaina 2019

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
19

Incidence of Cancer and Cancer-related Mortality Among Persons with Chronic Hepatitis C Infection, 2006–2010 mā Allison, Robert D., Tong, Xin, Moorman, Anne C., Ly, Kathleen N., Rupp, Loralee, Xu, Fujie, Gordon, Stuart C., Holmberg, Scott D.

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
20

Hepatitis C Retreatment in the Era of Direct-Acting Antivirals: Projections in the United States mā Chhatwal, Jagpreet, Chen, Qiushi, Ayer, Turgay, Bethea, Emily D., Kanwal, Fasiha, Kowdley, Kris V., Wang, Xiaojie, Roberts, Mark S., Gordon, Stuart C.

I whakaputaina 2018

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:

Ngā hua rapu - Gordon, Stuart C

Utility of IL-28B Polymorphisms in the Era of Direct-Acting Antiviral Therapy mā Gordon, Stuart C.

Polycystic Liver Disease mā Gordon, Stuart C.

Hepatitis C Virus Detection and Treatment in Rural Communities mā Gordon, Stuart C.

Update on Polycystic Liver Disease mā Gordon, Stuart C.

Epidemiology of Hepatitis C mā Jafri, Syed‐Mohammed, Gordon, Stuart C.

Is there still a role for liver biopsy in managing hepatitis C virus infections? mā Jafri, Syed‐Mohammed R., Gordon, Stuart C.

Management of Direct‐Acting Antiviral Failures mā Alimirah, Maryam, Sadiq, Omar, Gordon, Stuart C.

Response to: ‘No impact of Covid‐19 pandemic on decompensation of alcoholic liver disease: Results from a single Center in Milan’ mā Gonzalez, Humberto C., Rupp, Loralee B., Trudeau, Sheri, Gordon, Stuart C.

A randomized controlled trial of thymalfasin plus transarterial chemoembolization for unresectable hepatocellular carcinoma mā Gish, Robert G., Gordon, Stuart C., Nelson, David, Rustgi, Vinod, Rios, Israel

Assessment of cost of innovation versus the value of health gains associated with treatment of chronic hepatitis C in the United States: The quality-adjusted cost of care mā Younossi, Zobair M., Park, Haesuk, Dieterich, Douglas, Saab, Sammy, Ahmed, Aijaz, Gordon, Stuart C.

Health Care Use and Costs Among Patients With Nonalcoholic Steatohepatitis With Advanced Fibrosis Using the Fibrosis‐4 Score mā Gordon, Stuart C., Kachru, Nandita, Parker, Emily, Korrer, Stephanie, Ozbay, A. Burak, Wong, Robert J.

Validity of an automated algorithm using diagnosis and procedure codes to identify decompensated cirrhosis using electronic health records mā Lu, Mei, Chacra, Wadih, Rabin, David, Rupp, Loralee B, Trudeau, Sheri, Li, Jia, Gordon, Stuart C

A Case of Hemophagocytic Lymphohistiocytosis Secondary to Disseminated Histoplasmosis mā Columbus-Morales, Ivan, Maahs, Lucas, Husain, Sanam, Gordon, Stuart C., Inamdar, Kedar V., Gonzalez, Humberto C.

Real-world Comorbidity Burden, Health Care Utilization, and Costs of Nonalcoholic Steatohepatitis Patients With Advanced Liver Diseases mā Wong, Robert J., Kachru, Nandita, Martinez, Diane J., Moynihan, Meghan, Ozbay, A. Burak, Gordon, Stuart C.

Hepatitis B e Antigen Status and Hepatitis B DNA Levels in Women of Childbearing Age with Chronic Hepatitis B Infection Screening for Clinical Trials mā Tran, Tram T., Gordon, Stuart C., Fung, Scott, Dinh, Phillip, Yee, Leland, Martins, Eduardo Bruno, Buti, Maria, Marcellin, Patrick

Baricitinib and primary biliary cholangitis mā Gordon, Stuart C., Trudeau, Sheri, Regev, Arie, Uhas, Jonathan M., Chakladar, Sujatro, Pinto-Correia, Ana, Gottlieb, Klaus, Schlichting, Doug

Differences in Hepatic Phenotype Between Hemochromatosis Patients with HFE C282Y Homozygosity and Other HFE Genotypes mā Cheng, Raymond, Barton, James C., Morrison, Elizabeth D., Phatak, Pradyumna D., Krawitt, Edward L., Gordon, Stuart C., Kowdley, Kris V.

Advancing Age and Comorbidity in a US Insured Population‐Based Cohort of Patients With Chronic Hepatitis B mā Nguyen, Mindie H., Lim, Joseph K., Burak Ozbay, A., Fraysse, Jeremy, Liou, Iris, Meyer, Nicole, Dusheiko, Geoffrey, Gordon, Stuart C.

Incidence of Cancer and Cancer-related Mortality Among Persons with Chronic Hepatitis C Infection, 2006–2010 mā Allison, Robert D., Tong, Xin, Moorman, Anne C., Ly, Kathleen N., Rupp, Loralee, Xu, Fujie, Gordon, Stuart C., Holmberg, Scott D.

Hepatitis C Retreatment in the Era of Direct-Acting Antivirals: Projections in the United States mā Chhatwal, Jagpreet, Chen, Qiushi, Ayer, Turgay, Bethea, Emily D., Kanwal, Fasiha, Kowdley, Kris V., Wang, Xiaojie, Roberts, Mark S., Gordon, Stuart C.

Ngā utauta rapu: